SPRO Archived Articles
Spero Therapeutics (NASDAQ:SPRO) - Advancing Novel Treatments for Rare Diseases and Antibiotic Resistance
Published on November 19, 2024
Spero Therapeutics, Inc. (NASDAQ:SPRO) - A Promising Pipeline Targeting Rare Diseases and Resistant Infections
Published on September 24, 2024